Relmada Therapeutics

-$0.36 (-1.91%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist, which is a New Chemical Entity (NCE) that potentially addresses areas of high unmet medical need in the treatment of central nervous system (CNS) diseases and other disorders.

CEO
Sergio Traversa
Employees
14
Headquarters
Coral Gables, Florida
Founded
2012

RLMD Key Statistics

Market cap
502.02M
Price-Earnings ratio
—
Dividend yield
—
Average volume
123.76K
High today
$19.84
Low today
$18.15
Open price
$19.09
Volume
117.46K
52 Week high
$40.00
52 Week low
$16.34

RLMD Earnings

-$2.44
-$1.63
-$0.81
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 24, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure